, Tracking Stock Market Picks
Enter Symbol:
Biovail Corporation (BVF) [hlAlert]

up 1,558.89 %

Biovail Corporation (BVF) rated Overweight with price target $18 by Piper Jaffray

Posted on: Friday,  Dec 11, 2009  8:25 AM ET by Piper Jaffray

Piper Jaffray rated Overweight Valeant Pharmaceuticals International Inc (NYSE: VRX) on 12/11/2009, when the stock price was $14.16.
Since then, Valeant Pharmaceuticals International Inc has gained 1558.90% as of 01/06/2016's recent price of $234.90.
If you would have followed this Piper Jaffray's recommendation on VRX, you would have gained 1558.89% of your investment in 2217 days.

Biovail Corporation (Biovail) is a specialty pharmaceutical company that applies advanced drug-delivery technologies to improve the clinical effectiveness of medicines. The Company is engaged in the formulation, clinical testing, registration, manufacture and commercialization of pharmaceutical products. The Company has various research and development, clinical research, manufacturing and commercial operations located in Barbados, Canada, the United States and Puerto Rico. Its main therapeutic areas of focus are central nervous system (CNS) disorders, pain management and cardiovascular disease. The primary markets for its products are the United States and Canada. On September 16, 2008, Biovail acquired Prestwick Pharmaceuticals, Inc.

At Piper Jaffray, we understand there’s no substitute for relevant and timely research. That's why we provide: * fundamental and technical research * value-added investment ideas * market analysis With the information our research team provides, you’ll make better and more informed decisions for your portfolio.
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy